Identification of calcium-independent phospholipase A2gamma in mitochondria and its role in mitochondrial oxidative stress.
Oxidant-induced lipid peroxidation and cell death mediate pathologies associated with ischemia-reperfusion and inflammation. Our previous work in rabbit renal proximal tubular cells (RPTC) demonstrated that inhibition of Ca(2+)-independent phospholipase A(2) (iPLA(2)) potentiates oxidant-induced lipid peroxidation and necrosis, implicating iPLA(2) in phospholipid repair. This study was conducted to identify a RPTC mitochondrial PLA(2) and determine the role of PLA(2) in oxidant-induced mitochondrial dysfunction. iPLA(2) activity was detected in Percoll-purified rabbit renal cortex mitochondria (RCM) and in isolated mitochondrial inner membrane fractions from rabbit and human RCM. Immunoblot analysis and inhibitor sensitivity profiles revealed that iPLA(2)gamma is the RCM iPLA(2) activity. RCM iPLA(2) activity was enhanced in the presence of ATP and was blocked by the PKCepsilon V1-2 inhibitor. Oxidant-induced mitochondrial lipid peroxidation and swelling were accelerated by pretreatment with R-BEL, but not S-BEL. Furthermore, oxidant treatment of isolated RCM resulted in decreased iPLA(2)gamma activity. These results reveal that RCM iPLA(2) is iPLA(2)gamma, RCM iPLA(2)gamma is regulated by phosphorylation by PKCepsilon, iPLA(2)gamma protects RCM from oxidant-induced lipid peroxidation and dysfunction, and that a strategy to preserve or enhance iPLA(2)gamma activity may be of therapeutic benefit.
Kinsey
Gilbert R
GR
Dept. of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
McHowat
Jane
J
Beckett
Caroline S
CS
Schnellmann
Rick G
RG
D000818:Animals; D002083:Butylated Hydroxyanisole / Q000494:pharmacology; D005260:Female; D005296:Ferrous Compounds / Q000494:pharmacology; D054513:Group IV Phospholipases A2; D006801:Humans; D007672:Kidney Cortex / Q000648:ultrastructure; D008928:Mitochondria / Q000201:enzymology*; D008933:Mitochondrial Swelling / Q000187:drug effects; D009281:Naphthalenes / Q000494:pharmacology; D018384:Oxidative Stress / Q000502:physiology*; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000502:physiology*; D011753:Pyrones / Q000494:pharmacology; D011817:Rabbits
D005296:Ferrous Compounds; D009281:Naphthalenes; D011753:Pyrones; D002083:Butylated Hydroxyanisole; C068314:6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one; D010741:Phospholipases A; D054513:Group IV Phospholipases A2